GeneDx Holdings (WGS) Non Operating Income (2020 - 2026)

GeneDx Holdings (WGS) has reported Non Operating Income for 7 consecutive years, with -$803000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Income fell 150.09% year-over-year to -$803000.0 in Q2 2026; TTM through Jun 2026 was -$13.9 million, a 256.07% decrease from a year earlier, with the FY2025 full-year figure at -$8.1 million, up 72.6% from the prior year.
• Non Operating Income was -$803000.0 for Q2 2026 at GeneDx Holdings, up from -$4.9 million in the prior quarter.
• Over five years, Non Operating Income peaked at $27.8 million in Q2 2022 and troughed at -$18.8 million in Q2 2024.
• A 5-year average of $1.7 million and a median of -$675500.0 in 2023 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income soared 4003.23% in 2022 and plunged 762.82% in 2024, its largest moves.
• Over 5 years, Non Operating Income stood at $16.2 million in 2022, then plunged by 103.34% to -$541000.0 in 2023, then slumped by 526.99% to -$3.4 million in 2024, then dropped by 17.78% to -$4.0 million in 2025, then surged by 79.9% to -$803000.0 in 2026.
• The last three Non Operating Income figures came in at -$803000.0 (Q2 2026), -$4.9 million (Q1 2026), and -$4.0 million (Q4 2025), per Business Quant data.